How Do Info Tech Systems (ITS) Earnings Compare To High Profitability Narrative?

Info-Tech Systems (SGX:ITS) has reported its FY 2025 second half with revenue of S$34.1 million and basic EPS of S$0.034, against a trailing twelve month revenue base of S$56.5 million and EPS of S$0.058. The company has seen revenue move from S$30.8 million on a trailing basis in 2022 to S$56.5 million in 2025, while EPS shifted from S$0.032 to S$0.058 over the same period, alongside trailing earnings growth of 21.7% year on year. For investors, the key question now is how to read these earnings alongside a slightly softer net margin and relatively measured growth outlook.

See our full analysis for Info-Tech Systems.

With the headline results on the table, the next step is to see how these numbers stack up against the key stories investors usually focus on, and where the latest figures reinforce or challenge those views.

Curious how numbers become stories that shape markets? Explore Community Narratives

SGX:ITS Revenue & Expenses Breakdown as at Feb 2026
SGX:ITS Revenue & Expenses Breakdown as at Feb 2026
Advertisement

21.7% earnings growth with 26.6% margin

  • Over the last twelve months, net income was S$15.0 million on S$56.5 million of revenue, which works out to a 26.6% net margin compared with 28.2% a year earlier, alongside 21.7% earnings growth.
  • Bulls often focus on recurring software revenue and HR and accounting tools as long term themes. That view is partly supported here because strong 21.7% earnings growth and a 26.6% margin.
  • A major contributor to the margin slip from 28.2% was due to a one-off listing-related expense. This means investors have the appeal of decent profitability with a view to margins recovering next year.

Strong earnings growth against slower sales can be a key part of the bull story, and it is worth seeing how that is shaping the current debate on Info-Tech Systems. 📊 Read the what the Community is saying about Info-Tech Systems.

Low 17.5x P/E against industry 22x

  • The shares trade on a P/E of 17.5x compared with 22x for the wider Asian Software industry and 45.1x for peers, so the company sits at a discount to both groups on this metric.
  • What stands out for the more bullish camp is that this lower 17.5x P/E is paired with 21.7% trailing earnings growth. However, that enthusiasm is checked by forecasts that call for only 1.6% revenue growth and 2.2% earnings growth per year out to FY2028, so the current valuation support rests on the recent past rather than on faster growth projections.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Info-Tech Systems's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If strong earnings still leave you undecided, review the underlying numbers yourself and determine your own view. To see what the optimism in the data refers to, take a closer look at the 4 key rewards .

See What Else Is Out There

Info-Tech Systems pairs a 17.2x P/E and high margins with only modest annual revenue growth forecasts for the next 3 years, which may not suit growth-focused investors.

If you want revenue and earnings profiles that feel more compelling, check out our 229 high quality undervalued stocks that highlight companies where pricing may better reflect their growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SGX:ITS

Info-Tech Systems

Engages in the sale of cloud-based accounting software and human resource management software (HRMS) in Malaysia, and Singapore.

Very undervalued with flawless balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0